1-4 of 4
Andrea N Edginton
Close
Sort by
Journal Articles

A Real-World Population Pharmacokinetic (PK) Study of Two Recombinant Factor VIII (rFVIII) Concentrates in Boys with Severe Hemophilia a without Inhibitors

Viviane Grassmann, Dagmar M Hajducek, Andrea N Edginton, Vanessa Bouskill, Christine Brown, Manuel Carcao, David Lillicrap, Roxy H O'Rourke, Roona Sinha, Jayson Stoffman, Cindy Wakefield, Margaret L. Rand, Victor Blanchette
Journal: Blood
Blood (2022) 140 (Supplement 1): 8453–8455.
https://doi.org/10.1182/blood-2022-160289
Published: 2022
Journal Articles

Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform

Pierre Chelle, PhD, Cindy Yeung, MSc, Santiago Bonanad Boix, MD, Juan Cristobal Morales, MD, Margareth C Ozelo, MD PhD, Juan E. Megias Vericat, PharmD, Alfonso Iorio, MD PhD, Jeffrey Spears, PharmD, Roser Mir, PhD, Andrea N Edginton, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1191.
https://doi.org/10.1182/blood-2018-99-115308
Published: 2018
Journal Articles

Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study

Michaela Stemberger, Felix Kallenbach, Elisabeth Schmit, Alanna McEneny-King, Andrea N Edginton, PhD, Alfonso Iorio, MD PhD, Karin Kurnik
Journal: Blood
Blood (2017) 130 (Supplement 1): 2404.
https://doi.org/10.1182/blood.V130.Suppl_1.2404.2404
Published: 2017
Journal Articles

Comparative Assessment of the Performance of Pharmacokinetic Tools for Prophylactic Dosing of Antihemophilic Factor Recombinant Plasma/Albumin-Free Method (rAHF-PFM) Concentrate in Patients with Hemophilia A

Phillip Staibano, BSc, MSc, Alanna McEneny-King, MSc, PhDc), Massimo Morfini, MD, Gary Foster, PhD, Nicholas Hobson, Tamara Navarro-Ruan, MSc, Andrea N Edginton, PhD, Alfonso Iorio, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4934.
https://doi.org/10.1182/blood.V130.Suppl_1.4934.4934
Published: 2017